Skip to main content

Advertisement

Log in

CYP1A1 and GSTM1/T1 Genetic Variation in Predicting Risk for Cerebral Infarction

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Cytochrome P450 1A1 (CYP1A1) is involved in the production of arachidonic acid-derived vasoactive substance. We hypothesized that CYP1A1 polymorphism might be related to pathological conditions associated with cerebral infarction (CI). We investigated the effect of genetic polymorphism in the 3′-flanking region (T6235C) of CYP1A1 gene in 353 patients with CI and 376 controls. The distributions of T6235C CYP1A1 genotypes in patients with (TT: 36.0%; TC/CT: 64.0%; n = 353) and without CI (TT: 44.7%; TC/CT: 55.3%; n = 376) indicate that the C allele is associated with CI (P = 0.017, odds ratio (O.R.) = 1.44; 95% confidence interval (C. I.) = 1.07–1.94). Furthermore, we examined whether the glutathione S-transferase (GST) gene, which is one of detoxification enzyme, influence the risk of CI. GST M1 null genotype increased the relative risk for the CI in the subjects with the CYP1A1 C allele (P = 0.015, O.R. = 1.47; C. I. = 1.08–2.00). We conclude that T6235C CYP1A1 polymorphism is a risk factor for the development of CI and suggest that GST polymorphism contribute to the odds of CI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abdel-Rahman, S., Z., el-zein, R. A., Anwar, W. A., & Au, W. W. (1996). A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Letters, 107, 229–233.

    Article  PubMed  CAS  Google Scholar 

  • Albert, R. E., Vanderlaan, M., Burns, F. J., & Nishizumi, M. (1977). Effect of carcinogens on chicken atherosclerosis. Cancer Research, 37(7 Pt 1), 2232–2235.

    PubMed  CAS  Google Scholar 

  • Awajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N., & Watanabe, J. (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Letters, 263, 131–133.

    Article  Google Scholar 

  • Bouchardy, C., Wikman, H., Benhamou, S., Hirvonen, A., Dayer, P., & Husgafvel-Pursianinen, K. (1997). CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population. Biomarkers, 2, 131–134.

    Article  CAS  Google Scholar 

  • Brockmoller, J., Cascorbi, I., Kerb, R., & Roots, I. (1996). Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Research, 56, 3915–3925.

    PubMed  CAS  Google Scholar 

  • Cornelis, M. C., El-Sohemy, A., & Campos, H. (2004). Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. Journal of Medical Genetics, 41(10), 752–762.

    Article  PubMed  CAS  Google Scholar 

  • Crofts, F., Taioli, E., Trachman, J., Cosma, G. N., Currie, D., & Toniolo, P., et al. (1994). Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15(12), 2961–2963.

    Article  PubMed  CAS  Google Scholar 

  • Gaspar, P. A., Hutz, M. H., Salzano, F. M., Hill, K., Hurtado, A. M., Petzl-Erler, M. L., et al. (2002). Polymorphisms of CYP1a1, CYP2e1, GSTM1, GSTT1, and TP53 genes in Amerindians. American Journal of Physical Anthropology, 119(3), 249–256.

    Article  PubMed  Google Scholar 

  • Hayashi, S., Watanabe, J., Nakachi, K., & Kawajiri, K. (1991). Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. Journal of Biochemical (Tokyo), 110(3), 407–411.

    CAS  Google Scholar 

  • Hayes, J. D., & Pulford, D. J. (1995). The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical Reviews in Biochemistry and Molecular Biology, 30(6), 445–600.

    PubMed  CAS  Google Scholar 

  • Hirvonen, A., Pursianen, K. H., Karjalainen, A., Anttila, S., & Vainio, H. (1992). Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiology, Biomarkers & Prevention, 2, 481–485.

    Google Scholar 

  • Hong, Y. S., Chang, J. H., Kwon, O. J., Ham, Y. A., & Choi, J. H. (1998). Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Experimental and Molecular Medicine, 30, 192–198.

    PubMed  CAS  Google Scholar 

  • Indulski, J. A., & Lutz, W. (2000). Metabolic genotype in relation to individual susceptibility to environmental carcinogens. International Archives of Occupational and Environmental Health, 73(2), 71–85.

    Article  PubMed  CAS  Google Scholar 

  • Kang, D. (2003). Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women. Journal of Biochemistry and Molecular Biology, 36, 28–34.

    PubMed  CAS  Google Scholar 

  • Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.

    Article  PubMed  CAS  Google Scholar 

  • Mooney, L. A., Bell, D. A., Santella, R. M., Van Bennekum, A. M., Ottman, R., Paik, M., et al. (1997). Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis, 18(3), 503–509.

    Article  PubMed  CAS  Google Scholar 

  • Nebert, D. W., Nelson, D. R., Coon, M. J., Estabrook, R. W., Feyereisen, R., Fujii-Kuriyama, Y., et al. (1991). The P450 superfamily: Update on new sequences, gene mapping, and recommended nomenclature. DNA and Cell Biology, 10, 1–14.

    Article  PubMed  CAS  Google Scholar 

  • Nerurkar, P. V., Okinaka, L., Aoki, C., Seifried, A., Lum-Jones, A., Wilkens, L. R., et al. (2000). CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiology, Biomarkers and Prevention, 9(10), 1119–1122.

    PubMed  CAS  Google Scholar 

  • Nimura, Y., Yokoyama, S., Fujimori, M., Aoki, T., Adachi, T., Nasu, T., et al. (1997). Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer, 80, 852–857.

    Article  PubMed  CAS  Google Scholar 

  • Penn, A., & Snyder, C. (1988). Arteriosclerotic plaque development is ‘promoted’ by polynuclear aromatic hydrocarbons. Carcinogenesis, 9(12), 2185–2189.

    Article  PubMed  CAS  Google Scholar 

  • Randerath, E., Mittal, D., & Randerath, K. (1988). Tissue distribution of covalent DNA damage in mice treated dermally with cigarette ‘tar’: Preference for lung and heart DNA. Carcinogenesis, 9(1), 75–80.

    Article  PubMed  CAS  Google Scholar 

  • Sharma, P. (1996). Genes for ischaemic stroke: Strategies for their detection. Journal de l'hypertension, 14, 277–285.

    Article  CAS  Google Scholar 

  • Shields, P. G., Caporaso, N. E., Falk, R. T., Sugimura, H., Trivers, G. E., Trump, B. F., et al. (1993). Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiology, Biomarkers and Prevention, 2, 481–485.

    PubMed  CAS  Google Scholar 

  • Solus, J. F., Arietta, B. J., Harris, J. R., Sexton, D. P., Steward, J. Q., McMunn, C., et al. (2004). Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics, 5(7), 895–931.

    Article  PubMed  CAS  Google Scholar 

  • Um, J. Y., An, N. H., Kim, S. H., Lee, K. M., Kim, Y. S., Jang, H., et al. (2003). Genetic susceptibility to ischemic cerebrovascular disease in Koreans. Journal of Molecular Neuroscience, 20(1), 31–38.

    Article  PubMed  CAS  Google Scholar 

  • Um, J. Y., Kim, H. M., Han, S. H., Cho, K. H., Moon, B. S., & Hong, S. H. (2006). Glutathione s-transferase gene polymorphism and ischemic cerebrovascular disease. International Journal of Neuroscience, 116(1), 55–65.

    Article  PubMed  CAS  Google Scholar 

  • Wang, X. L., Greco, M., Sim, A. S., Duarte, N., Wang, J., & Wilcken, D. E. (2002). Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis, 162, 391–397.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by the SRC program of KOSEF (R11-2005-014).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jae-Young Um.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moon, KS., Lee, HJ., Hong, SH. et al. CYP1A1 and GSTM1/T1 Genetic Variation in Predicting Risk for Cerebral Infarction. J Mol Neurosci 32, 155–159 (2007). https://doi.org/10.1007/s12031-007-0028-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-007-0028-1

Keywords

Navigation